Clinical Trial Update: Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabinoids as a treatment strategy for Alzheimer's disease has been completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: Federal University of Latin American Integration | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED